293 results on '"Posch F"'
Search Results
2. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients
3. Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
4. 123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE)
5. Benefit of adjuvant radiotherapy for local control, distant metastasis, and survival outcomes in patients with localized soft tissue sarcoma: comparative effectiveness analysis of an observational cohort study
6. Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma (STS) after curative resection: a multi-state model [Poster]
7. Conditional survival of patients with soft tissue sarcoma (STS) after curative resection [Poster]
8. Local recurrence, distant metastasis, and death in patients with soft tissue sarcoma after curative resection using a multi-state model
9. Untersuchung des Benefits der adjuvanten Radiotherapie in Bezug auf Lokalkontrolle, Fernmetastasierung und Überleben bei PatientInnen mit lokalisiertem Weichteilsarkom mittels vergleichender Effektivitätsanalyse [Poster]
10. How long should we follow-up patients with stage I non-small cell lung cancer after curative resection? An analysis of 300 cases using flexible parametric modeling of tumor recurrence and mortality rates [Poster]
11. Prediction of clinical outcomes in stage I non-small cell lung cancer after curative surgery focusing on the preoperative Glasgow Prognostic Score and inflammatory biomarkers
12. Lymphopenie als Prädiktor bei TKI-Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinom
13. Estimated versus measured glomerular filtration rate to evaluate kidney function in patients with cancer undergoing cisplatin-based chemotherapy [Poster]
14. Lymphopenia impairs response to 1st-line therapy with sunitinib and pazopanib in patients with metastatic clear-cell renal cell carcinoma [Abstract]
15. Definitive chemoradiotherapy with or without induction chemotherapy for unresectable squamous cell carcinoma of the head & neck: a propensity-score analysis [Abstract]
16. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality
17. Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer [Poster]
18. External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer [Poster]
19. Association of serum glucose levels with disease free survival in soft tissue sarcoma patients [Poster]
20. Individualized cancer treatment based on molecular profiling of circulating tumor DNA in patients with advanced and refractory carcinoma: a prospective phase II trial [Abstract]
21. FOLFIRINOX versus Gemcitabine/nab-Paclitaxel as palliative first-line treatment of advanced pancreatic cancer: an Austrian observational Tri-Center comparative effectiveness analysis [Abstract]
22. Incidence, prediction and outcome of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of Gemcitabine/nab-Paclitxel or FOLFIRINOX [Poster]
23. Early CRP kinetics after initiation of immune checkpoint inhibitors is a predictive biomarker for treatment response independent of the tumor antity [Poster]
24. Long-term cardiovascular complications in stage I seminoma patients
25. P11.01.B Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: A prospective study
26. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
27. Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause
28. PO-13: Lower-extremity deep vein thrombosis and bleeding complications in primary brain tumor patients: a prospective study
29. Serum integrin-linked kinase (sILK) concentration and survival in non-small cell lung cancer: a pilot study
30. Podoplanin expression and intravascular platelet aggregates: the missing link between cancer and thrombosis in primary malignant brain tumors: OR357
31. A network meta-analysis comparing the efficacy and safety of anticoagulants for the treatment of venous thromboembolism in cancer patients: OR260
32. Hypercoagulability, venous thromboembolism and death in patients with cancer: a multi-state model: OR227
33. Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
34. Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer—a nationwide analysis
35. 194P Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study
36. Single-stage revision for the infected total knee replacement: RESULTS FROM A SINGLE CENTRE
37. PO-89 Performance of the ‘4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
38. PO-92 Evaluation of gemcitabine and platinum agents for the prediction of venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis Study
39. PO-67 Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired versus outpatient) at diagnosis in the era of incidental events
40. Hilfestellung zur sinnvollen Indikation der Metastasektomie bei metachron metastasierten Nierenzellkarzinompatienten
41. Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II individualized cancer treatment trial
42. Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis [Poster]
43. Hilfestellung zur sinnvollen Indikation der Metastasektomie bei metachron metastasierten Nierenzellkarzinompatienten
44. 1938P Profiling of circulating tumour DNA for treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage phase II individualized cancer treatment trial
45. 113P C-reactive protein (CRP) levels in immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer: A bi-center study
46. 1552P Patterns of venous and arterial thromboembolism in patients with advanced pancreatic cancer treated with palliative first line chemotherapy of gemcitabine/nab-paclitxel or FOLFIRINOX
47. 1530P Gemcitabine/nab-paclitaxel versus (modified) FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
48. Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy
49. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
50. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.